These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3021800)
1. The selection and characterization of human monoclonal antibodies to human cytomegalovirus. Redmond MJ; Leyritz-Wills M; Winger L; Scraba DG J Virol Methods; 1986 Aug; 14(1):9-24. PubMed ID: 3021800 [TBL] [Abstract][Full Text] [Related]
2. Human monoclonal antibodies to human cytomegalovirus derived from peripheral blood lymphocytes of healthy adults. Kitamura K; Yamada K; Kuzushima K; Morishima T; Morishima Y; Yamamoto N; Nishiyama Y; Ohya K; Yamaguchi H J Med Virol; 1990 Sep; 32(1):60-6. PubMed ID: 2173739 [TBL] [Abstract][Full Text] [Related]
3. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities. Gupta CK; Leszczynski J; Gupta RK; Siber GR Biologicals; 1996 Jun; 24(2):117-24. PubMed ID: 8889058 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal IgM antibodies from cytomegalovirus-infected mice recognize the GlcNAc-containing receptor determinant of murine CMV as well as neutralizing anti-CMV IgG antibodies. Ravindranath RM; Graves MC Virology; 1992 May; 188(1):143-51. PubMed ID: 1373551 [TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies to human cytomegalovirus. Foung SK; Perkins S; Bradshaw P; Rowe J; Rabin LB; Reyes GR; Lennette ET J Infect Dis; 1989 Mar; 159(3):436-43. PubMed ID: 2536787 [TBL] [Abstract][Full Text] [Related]
6. Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus. Kim KS; Sapienza VJ; Chen CM; Wisniewski K J Clin Microbiol; 1983 Aug; 18(2):331-43. PubMed ID: 6194174 [TBL] [Abstract][Full Text] [Related]
7. Comparison of complement fixation, immunofluorescence and immunoenzymatic tests for routine detection of cytomegalovirus IgG antibodies. Ammendolia L; Andreoni M; Tosco P; Volpi A Boll Ist Sieroter Milan; 1984 Jul; 63(3):216-8. PubMed ID: 6095883 [TBL] [Abstract][Full Text] [Related]
8. Isolation of human monoclonal antibodies that neutralize human rotavirus. Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854 [TBL] [Abstract][Full Text] [Related]
9. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. Funaro A; Gribaudo G; Luganini A; Ortolan E; Lo Buono N; Vicenzi E; Cassetta L; Landolfo S; Buick R; Falciola L; Murphy M; Garotta G; Malavasi F BMC Biotechnol; 2008 Nov; 8():85. PubMed ID: 19014469 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement. Eizuru Y; Ueno I; Minamishima Y J Clin Microbiol; 1988 Sep; 26(9):1881-3. PubMed ID: 2846652 [TBL] [Abstract][Full Text] [Related]
11. A human monoclonal antibody to cytomegalovirus (CMV). Emanuel D; Gold J; Colacino J; Lopez C; Hammerling U J Immunol; 1984 Oct; 133(4):2202-5. PubMed ID: 6088634 [TBL] [Abstract][Full Text] [Related]
12. Properties of IgG subclasses to human cytomegalovirus. Gilljam G; Wahren B J Virol Methods; 1989 Aug; 25(2):139-51. PubMed ID: 2550502 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay. Lewis RB; Matzke DS; Albrecht TB; Pollard RB Rev Infect Dis; 1986; 8 Suppl 4():S434-8. PubMed ID: 3018894 [TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus. Alexander H; Harpprecht J; Podzuweit HG; Rautenberg P; Müller-Ruchholtz W Hum Antibodies Hybridomas; 1994; 5(1-2):81-90. PubMed ID: 7858186 [TBL] [Abstract][Full Text] [Related]
15. Development of human monoclonal antibodies against human cytomegalovirus. Kanoh Y; Yunoki M; Taniguchi T; Suzuki Y; Ideno S; Morita E; Hirama M; Yokoyama K; Yamanishi K Hybridoma; 1992 Oct; 11(5):569-79. PubMed ID: 1281135 [TBL] [Abstract][Full Text] [Related]
16. A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors. Corrales-Aguilar E; Trilling M; Reinhard H; Mercé-Maldonado E; Widera M; Schaal H; Zimmermann A; Mandelboim O; Hengel H J Immunol Methods; 2013 Jan; 387(1-2):21-35. PubMed ID: 23023090 [TBL] [Abstract][Full Text] [Related]
17. A combination of human cytomegalovirus (HCMV)-specific murine monoclonal antibodies exhibits synergistic antiviral activity in vitro. Gehrz RC; Nelson CM; Kari BE Antiviral Res; 1992 Feb; 17(2):115-31. PubMed ID: 1313219 [TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Nowak B; Sullivan C; Sarnow P; Thomas R; Bricout F; Nicolas JC; Fleckenstein B; Levine AJ Virology; 1984 Jan; 132(2):325-38. PubMed ID: 6322416 [TBL] [Abstract][Full Text] [Related]
19. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization. Endresz V; Kari L; Berencsi K; Kari C; Gyulai Z; Jeney C; Pincus S; Rodeck U; Méric C; Plotkin SA; Gönczöl E Vaccine; 1999 Jan; 17(1):50-8. PubMed ID: 10078607 [TBL] [Abstract][Full Text] [Related]
20. Syngeneic monoclonal anti-idiotype antibodies that bear the internal image of a human cytomegalovirus neutralization epitope. Keay S; Rasmussen L; Merigan TC J Immunol; 1988 Feb; 140(3):944-8. PubMed ID: 2448380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]